Sunday, September 13 • 11:00am - 12:15pm
Avoiding Polypharmacy in the Pharmacologic Treatment of Borderline Personality Disorder

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

There is no evidence for the effectiveness of polypharmacy in the treatment of borderline personality disorder (BPD), yet clinical experience reveals that many patients with BPD often take 2 or more medications simultaneously. In addition to the lack of data to support clinical improvement from this multiple psychotropic medication approach, the use of polypharmacy has a much greater chance of inducing adverse effects and weight gain than it does in leading to clinical improvement. This session will review the value, as well as the limitations, of psychopharmacologic treatment in BPD in order to mitigate the current propensity toward polypharmacy.

avatar for Kenneth Silk, MD

Kenneth Silk, MD

Professor Emeritus of Psychiatry, University of Michigan Health System, Ann Arbor, MichiganKenneth Silk, MD went to Brandeis University and then to Albert Einstein College of Medicine in the Bronx. He did a pediatric internship at Montefiore Hospital in the Bronx and a residency in... Read More →
avatar for Victor Hong, MD

Victor Hong, MD

Clinical Instructor, Department of Psychiatry, University of Michigan Health System, Ann Arbor, MichiganVictor Hong, MD attended the University of California at Berkeley, where he received his bachelor’s degree in English Literature, then Loma Linda University School of Medicine... Read More →

Sunday September 13, 2015 11:00am - 12:15pm PDT

Attendees (0)